Lataa...
Erythropoietin-induced Neuroprotection Requires Cystine Glutamate Exchanger Activity
Erythropoietin (Epo) has been used for many years in neonates for the treatment of anemia of prematurity. Epo has also been proposed for treatment of neonatal brain injury, as mounting evidence suggests neuroprotective properties for Epo. However, Epo’s neuroprotective mechanism of action is poorly...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2010
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2840049/ https://ncbi.nlm.nih.gov/pubmed/20102705 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.brainres.2010.01.040 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|